Last reviewed · How we verify
Urethritis due to Chlamydia trachomatis
Approved treatments
- Azo Gantrisin · Alra
- E-Mycin · Generic (originally Abbott/Lilly)
- Zithromax · Pfizer Inc.
Macrolide antibiotic that binds the 50S ribosomal subunit, inhibiting bacterial protein synthesis with an exceptionally long tissue half-life. - Tomefloxacin · Otsuka
- Benzamycin · Pfizer
- Noroxin
- Floxin
- Ofloxacine · Assistance Publique - Hôpitaux de Paris
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Urethritis due to Chlamydia trachomatis patent landscape — cliff calendar, originator estates, attackable patents
- Urethritis due to Chlamydia trachomatis treatment landscape brief
- Urethritis due to Chlamydia trachomatis treatment updates RSS
Frequently asked questions about Urethritis due to Chlamydia trachomatis
What drugs treat Urethritis due to Chlamydia trachomatis?
Tracked treatments include Azo Gantrisin, E-Mycin, Zithromax, Tomefloxacin, Benzamycin, Noroxin, Floxin, Ofloxacine.
What is the treatment for Urethritis due to Chlamydia trachomatis?
Standard treatment for Urethritis due to Chlamydia trachomatis includes Azo Gantrisin, E-Mycin, Zithromax, Tomefloxacin, Benzamycin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Urethritis due to Chlamydia trachomatis patent cliff · Urethritis due to Chlamydia trachomatis CI report
- Treatment: Azo Gantrisin · Alra
- Treatment: E-Mycin · Generic (originally Abbott/Lilly)
- Treatment: Zithromax · Pfizer Inc.
- Treatment: Tomefloxacin · Otsuka
- Treatment: Benzamycin · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing